Health
FDA Authorizes Marketing of Device to Improve Gait in Multiple Sclerosis Patients – WebWire
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use as a short-term treatment of gait deficit due to mild to moderate…
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use as a short-term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis (MS). The device is intended to be used by prescription only as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and older. The device, called Portable Neuromodulation Stimulator (PoNS), is a neuromuscular tongue stimulator that consists of a non-implantable apparatus…
-
General21 hours agoEmergency operation underway after reports of bodies north-east of Falls Creek
-
Noosa News24 hours agoRetail worker allegedly raped at gunpoint before 3½-hour kidnapping ordeal
-
Noosa News23 hours agoPSPA declared, Camp Mountain – Sunshine Coast
-
Noosa News22 hours agoExclusion zone declared as bushfire sparks major emergency response near Brisbane